Search - tctmd.com

Displaying 21 - 38 of 38

Sort: Relevancy | Date

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation TVT 2016

What Do I Do With a Patient With Cryptogenic Stroke?

Presenter: Creighton W. Don

June 18, 2016

Presentation

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Presenter: Pablo Rengifo

October 29, 2015

Presentation TCT 2015

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Long-term Results

Presenter: John D. Carroll, Ioanna Kosmidou

October 15, 2015

Presentation TCT 2015

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke – Long-term Results

Presenter: John D. Carroll

October 15, 2015

Presentation

PFO Closure Following Cryptogenic Stroke or TIA

Presenter: Mikaeil Mirzaali

July 02, 2015

Presentation

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

Presenter: Christopher A. Pickett

September 30, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Presenter: S. Elmariah

August 20, 2014

Presentation

Cryptogenic Stroke and Underlying A-fib

Presenter: Tomasso Sanna

July 01, 2014

Presentation

A-fib in Patients with Cryptogenic Stroke or TIA

Presenter: D.J. Gladstone

July 01, 2014

Presentation ECHO 2013

Advanced TEE: Clinical Decision Making in Cryptogenic Stroke and Atrial Fibrillation

Presenter: Marco R. Di Tullio

April 04, 2013

Presentation

RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke

Presenter: John D. Carroll

March 20, 2013

Presentation

PFO Closure for Cryptogenic Stroke - RESPECT and PC Trials: Critique and Interpretation

Presenter: Gregg W. Stone

November 08, 2012

Presentation TCT 2012

RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke

Presenter: John Carroll

October 25, 2012

Presentation TCT 2012

Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives

Presenter: David Thaler

October 22, 2012

Presentation

Patent Foramen Ovale (PFO) Closure for Cryptogenic Stroke: Neurologists’ Perspective

Presenter: James Grotta

May 02, 2012

Presentation

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Presenter: Anthony J. Furlan

March 14, 2012

Advertisement

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

What Do I Do With a Patient With Cryptogenic Stroke?

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Long-term Results

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke – Long-term Results

PFO Closure Following Cryptogenic Stroke or TIA

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Cryptogenic Stroke and Underlying A-fib

A-fib in Patients with Cryptogenic Stroke or TIA

Advanced TEE: Clinical Decision Making in Cryptogenic Stroke and Atrial Fibrillation

RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke

PFO Closure for Cryptogenic Stroke - RESPECT and PC Trials: Critique and Interpretation

RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke

Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives

Patent Foramen Ovale (PFO) Closure for Cryptogenic Stroke: Neurologists’ Perspective

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content